{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:21:57Z","timestamp":1790086917853,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ctro.2022.05.007","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T12:32:40Z","timestamp":1654086760000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment"],"prefix":"10.1016","volume":"36","author":[{"given":"Zachary A.","family":"Seymour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Daignault-Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.W.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skyler B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Hamstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ctro.2022.05.007_b0005","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Eng J Med"},{"issue":"2","key":"10.1016\/j.ctro.2022.05.007_b0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.radonc.2015.07.016","article-title":"Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy","volume":"116","author":"Evans","year":"2015","journal-title":"Radiother Oncol"},{"issue":"24","key":"10.1016\/j.ctro.2022.05.007_b0015","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2008.18.6486","article-title":"Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function","volume":"27","author":"Chen","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2022.05.007_b0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijrobp.2007.12.024","article-title":"Health related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer","volume":"72","author":"Ferrer","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2022.05.007_b0025","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods, and major patters in GLO-BOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctro.2022.05.007_b0030","first-page":"9","article-title":"Cancer statistics. 2014","volume":"64","author":"Siegal","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctro.2022.05.007_b0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.brachy.2018.01.008","article-title":"Quality of life up to 10 years after external beam radiotherapy and\/or brachytherapy for prostate cancer","volume":"17","author":"Freiberger","year":"2018","journal-title":"Bachytherapy"},{"issue":"4","key":"10.1016\/j.ctro.2022.05.007_b0040","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.eururo.2014.08.074","article-title":"Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE Registry","volume":"68","author":"Punnen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2022.05.007_b0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11764-014-0419-6","article-title":"Long-term health-related quality of life for prostate cancer survivors varies by primary treatment. Results from PiCTure Study","volume":"9","author":"Drummond","year":"2015","journal-title":"J Cancer Surviv"},{"issue":"5","key":"10.1016\/j.ctro.2022.05.007_b0050","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer","volume":"368","author":"Resnick","year":"2013","journal-title":"NEJM"},{"issue":"31","key":"10.1016\/j.ctro.2022.05.007_b0055","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1200\/JCO.2009.25.3245","article-title":"Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment","volume":"28","author":"Pardo","year":"2010","journal-title":"JCO"},{"issue":"15","key":"10.1016\/j.ctro.2022.05.007_b0060","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"NEJM"},{"issue":"5","key":"10.1016\/j.ctro.2022.05.007_b0065","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ijrobp.2013.08.019","article-title":"Health related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials","volume":"87","author":"King","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2022.05.007_b0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2002.20.2.557","article-title":"Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer","volume":"20","author":"Wei","year":"2002","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2022.05.007_b0075","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO.2005.07.116","article-title":"Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy","volume":"23","author":"Miller","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.05.007_b0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.urology.2014.08.044","article-title":"Minimally important difference for the expanded prostate cancer index composite short form","volume":"85","author":"Skolarus","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.ctro.2022.05.007_b0085","article-title":"Fifteen yuear quality of life outcomes in men with localized prostate cancer: population based Australian prospective study","volume":"371","author":"Mazariego","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ctro.2022.05.007_b0090","doi-asserted-by":"crossref","unstructured":"Talcott, Peiker P, Propert KJ, et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. 1997;89(15):1117\u201323.","DOI":"10.1093\/jnci\/89.15.1117"},{"issue":"29","key":"10.1016\/j.ctro.2022.05.007_b0095","doi-asserted-by":"crossref","first-page":"e11297","DOI":"10.1097\/MD.0000000000011297","article-title":"Intrafascial nerve-sparing radical prostatectomy improves patients\u2019 postoperative contincence recovery and erectile function: a pooled analysis based on available literatures","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ctro.2022.05.007_b0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of M.D. Anderson randomized dose escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2022.05.007_b0105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ijrobp.2009.09.015","article-title":"Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial","volume":"78","author":"Nguyen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2022.05.007_b0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-5347(05)65395-5","article-title":"Late normal tissue sequelae in the second decad after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer","volume":"167","author":"Gardner","year":"2002","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ctro.2022.05.007_b0115","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ijrobp.2005.02.050","article-title":"Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy","volume":"62","author":"Ashman","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2022.05.007_b0120","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijrobp.2013.01.036","article-title":"Multi-institutional prospective evaluation of biowel quality of life after prostate external beam radiation therapy identifies patient and treatment specific factors with patient reported outomces: the PROSTQA experience","volume":"86","author":"Hamstra","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1067","key":"10.1016\/j.ctro.2022.05.007_b0125","doi-asserted-by":"crossref","first-page":"20160312","DOI":"10.1259\/bjr.20160312","article-title":"Target margins in radiotherapy of prostate cancer","volume":"89","author":"Yartsev","year":"2016","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.ctro.2022.05.007_b0130","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.ijrobp.2007.11.067","article-title":"Virtual HDR CyberKnife treatment for localized prostatic carcinioma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations","volume":"70","author":"Fuller","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2022.05.007_b0135","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/j.prro.2015.02.001","article-title":"Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer","volume":"5","author":"Seymour","year":"2015","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2022.05.007_b0140","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic body radiatio therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies","volume":"104","author":"Jackson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2022.05.007_b0145","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.12.024","article-title":"Continued benefit of rectal separation for prostate radiation therapy: final results of a phase III trial","volume":"97","author":"Hamstra","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2022.05.007_b0150","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.prro.2017.07.008","article-title":"Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with rectal\/prosate space: secondary analysis of a phase 3 trial","volume":"8","author":"Hamstra","year":"2018","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2022.05.007_b0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brachy.2013.08.005","article-title":"Declining use of brachytherapy for the treatment of prostate cancer","volume":"13","author":"Mahmood","year":"2014","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.ctro.2022.05.007_b0160","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.eururo.2017.06.020","article-title":"Brachytherapy boost utilization and survival in unfavorable risk prostate cancer","volume":"72","author":"Johnson","year":"2017","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.ctro.2022.05.007_b0165","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2018.0587","article-title":"Radical prostatectomy, external beam radiaotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in paitents with gleason score 9\u201310 prostate cancer","volume":"319","author":"Kishan","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ctro.2022.05.007_b0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamaoncol.2018.4836","article-title":"Surgery vs radiotherapy in the management of biopsy gleason 9\u201310 prostate cancer and the risk of mortality","volume":"5","author":"Tilki","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2022.05.007_b0175","doi-asserted-by":"crossref","DOI":"10.1097\/01.ju.0000113299.34404.22","article-title":"High dose rate brachytherapy prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds","volume":"171","author":"Grills","year":"2004","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ctro.2022.05.007_b0180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0360-3016(00)00433-8","article-title":"Urinary morbidity with modified peripheral loading technique of transperinal (125)I prostate implantation","volume":"47","author":"Brown","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630822000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630822000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:10:01Z","timestamp":1762503001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630822000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":36,"alternative-id":["S2405630822000441"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2022.05.007","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2022.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}